© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Ambrx Biopharma Inc. (AMAM) shows an Average True Range (ATR) of 0.18 and an Enterprise Value of 1.56B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into AMAM's underlying financial health and market activity.
Ambrx Biopharma Inc. (AMAM) technical indicators as of December 22, 2025: the SMA 20 is 0.5%, SMA 50 at 10.56%, and SMA 200 at 75.14%. The RSI 14 value is 82.21, suggesting its current momentum. These technical analysis signals help assess AMAM's price trends and potential future movements.
Ambrx Biopharma Inc. (AMAM) stock performance overview as of December 22, 2025: The 52-week high is N/A (currently -0.53% below), and the 52-week low is N/A (currently 327.48% above). Over the past year, AMAM's performance is 1,433.15%, compared to the S&P 500's 12.87% change.
According to market data, Ambrx Biopharma Inc. (AMAM) stock's recent performance metrics show that over the last month, AMAM is -0.79%, with a Year-to-Date (YTD) performance of 94.87%. Over the past year, the stock has seen a 1,433.15% change. These figures summarize AMAM's price movements across various periods, reflecting its historical returns.
According to current financial data, AMAM stock's P/E (TTM) ratio is -13.86, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for AMAM, including P/S (239.41), P/B (9.17), and P/FCF (-25.41), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.